gdc

Web Exclusives

Acalabrutinib Shows Superior Efficacy Over Chemoimmunotherapy
CLL Monthly MinutesLeukemia
Results from the 4-year follow-up of the ELEVATE-TN study support acalabrutinib with or without immunotherapy in previously untreated patients with chronic lymphocytic leukemia.
Maintaining an Intimate Relationship After a Cancer Diagnosis
CLL Monthly MinutesLeukemia
Being diagnosed with cancer and undergoing subsequent treatment can be challenging for patients and their partners, but intimacy does not have to end.
How Patients with Cancer Can Overcome Feelings of Isolation
COVID-19 & Cancer
Patients with cancer can take a proactive role in their overall well-being by finding out what types of activities work best for them to combat feelings of isolation.
Staying Up to Date on Vaccines for Patients with Childhood Cancer
COVID-19 & CancerPediatric Cancer
As we recognize National Immunization Awareness Month, let’s focus on building awareness of the latest vaccination guidance and requirements to support parents of children and teens with pediatric cancer.
What Is a Patient Advocate, and How Do I Become One?
Patient Advocacy
Cancer treatment is complicated; an oncology patient advocate can help uncomplicate the journey by advocating and being a voice for their patients with cancer.
A Look at Acalabrutinib Clinical Trials
CLL Monthly MinutesLeukemia
Ongoing clinical trials are poised to expand the role of acalabrutinib in treating chronic lymphocytic leukemia.
What Your Doctor Should Know About Your Quality of Life
CLL Monthly MinutesLeukemia
Chronic lymphocytic leukemia can have a negative effect on patients’ quality of life, but healthcare teams may be able to minimize the impact.
Lowering the Dose May Not Mean Less Effective Treatment
CLL Monthly MinutesLeukemia
Low-dose chemoimmunotherapy may be an effective first-line therapy for certain patients with chronic lymphocytic leukemia and particular biological and genetic features.
Page 3 of 22
Results 21 - 30 of 214

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest